Cayley Russell, Jenna Ashley, Farihah Ali, Nikki Bozinoff, Kim Corace, David Marsh, Christopher Mushquash, Jennifer Wyman, Maria Zhang, Shannon LangeDaily supervised Opioid Agonist Treatment (OAT) medication has been identified as a barrier to treatment retention. Canadian OAT guidelines outline take-home dose (THD) criteria, yet, OAT prescribers use their clinical… |